24/7 Customer Service (800) 927-7671

Poietis Expands Medical Possibilities with Laser Bioprinting

by • February 14, 2016 • No Comments

Companies utilizing 3D bioprinting have promised their innovation can revolutionize the way medical companies perform testing. Eventually firms, such as Organovo, hope to regularly print tissues and organs for patient transplants. French firm Poietis has turn it intod a new method of bioprinting which they believe to be additional effective than which of the competition.

Bioimpression 4D BioPrinter from poietis

Most bioprinters rely on tiny valves to release cells during printing. Whilst pretty effective, this can injure the cells and lead to an increased rate of cell mortality. To solve this issue, Poietis is utilizing a high-definition laser to deposit the cells. The laser is reflected off of a mirror and and so passes through a layer of bio-ink which exactly deposits cells onto the turn it into plate. They’ve named the process Bioimpression 4D. The fourth dimension is the time required for cellular organization to form.

Poietis says their maximum resolution is 20 microns per layer, and ten-thousand drops can be deposited equite 2nd while maintaining 100% cell viability. These impressive specifications are what manufacture the Bioimpression 4D process the initially bioprinting innovation which can turn it into fully customized tissue. So far, they’ve that successfully printed human skin tissue which’s virtually identical to naturally occurring tissue.

Poietis Cell Deposits for Bioprinting

With over 35 years of combined industry experience, Fabian Guillemot (below) and Bruno Bisson founded Poietis late 2014. During summer 2015, they launched a hugely successful crowdfunding campaign on WiSEED. They managed to raise double the starting goal, and ended up with $1.35 million. Today, they’re comprised of a tiny team of 19 experts, and just plan to hire 6 additional inside the upcoming two years.

Fabian w Bioimpression 4D BioPrinter from poietis

Poietis’ innovation is yet in the research phase, but they hope to release a product onto the commercial market in 2017. They foresee the printed skin tissue as replacing animal testing by the cosmetics and pharmaceutical industries. Poietis may prove to be a quite profitable venture as forecasts indicate which the market for manufactured tissues may be $30 billion by 2018.

Latest posts

by admin • March 5, 2017